Cabotegravir-Rilpivirine: The First Complete Long-Acting Injectable Regimen for the Treatment of HIV-1 Infection.

Spencer H. Durham,Elias B. Chahine

Cabotegravir-Rilpivirine: The First Complete Long-Acting Injectable Regimen for the Treatment of HIV-1 Infection.

2021

Spencer H. Durham
Elias B. Chahine

Objective:To review the efficacy and safety of cabotegravir (CAB) with rilpivirine (RPV) in the treatment of HIV-1 infection.Data Sources:A literature search was performed using PubMed and Google S...

Keywords:

Clinical trial
Regimen
HIV/AIDS
long acting
Rilpivirine
Medicine
Internal medicine
Cabotegravir
human immunodeficiency virus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations